Silvia Morlupi

Silvia Morlupi has a diverse work experience in the pharmaceutical and research fields. In 2023, they worked at CAI as a Quality Compliance and Regulatory professional. Prior to that, in 2022, they were a Regulatory Affairs Associate at STERLING SPA. From 2021 to 2022, they served as a Quality Assurance Technician at The Janssen Pharmaceutical Companies of Johnson & Johnson. In 2019, Silvia worked as a Graduate Research Fellow at the University of Milan, where they conducted plasmacellular clonal research. Silvia also had a trainee position at TES PHARMA S.R.L. in 2019, where they focused on cancer and metabolic disorders research and gained expertise in molecular biology and microbiology techniques. In 2018, they were a trainee at MAASTRO (Maastricht Radiation Oncology Lab), where they studied the role of NOTCH signaling in primary lung stem cells. Lastly, they completed an undergraduate internship at CREO (Centre of Hemato-Oncology Research) in 2017, where they studied BCOR mutations in acute myeloid leukemia. Silvia has demonstrated proficiency in various laboratory techniques and research methodologies throughout their career.

Silvia Morlupi's education history includes attending the Quality Assurance Academy in 2020, where they completed a course on Quality Assurance and GMP compliance. Prior to that, from 2015 to 2018, they pursued a Master's degree in Cellular and Molecular Biology at the Università degli Studi di Torino. Before their Master's degree, from 2012 to 2015, Silvia studied at the Università degli Studi di Perugia, where they obtained a 1° livello - Laurea L in Biologia/Scienze biologiche, generale.